Medical Oncology (MO) communicates the results of clinical and experimental research in oncology and hematology, particularly experimental therapeutics within the fields of immunotherapy and chemotherapy. It also provides state-of-the-art reviews on clinical and experimental therapies. Topics covered include immunobiology, pathogenesis, and treatment of malignant tumors.
医学肿瘤学（MO）交流肿瘤学和血液学的临床和实验研究结果，特别是免疫治疗和化疗领域的实验治疗。它还提供了最先进的临床和实验治疗的审查。主题包括免疫生物学、发病机制和恶性肿瘤的治疗。
The role of vascular endothelial growth factor in the hypoxic and immunosuppressive tumor microenvironment: perspectives for therapeutic implications
来源期刊：Medical OncologyDOI：10.1007/s12032-019-1329-2
Interaction between phytotherapy and oral anticancer agents: prospective study and literature review
来源期刊：Medical OncologyDOI：10.1007/s12032-019-1267-z
Real-world outcomes in patients with unresected stage III non-small cell lung cancer
来源期刊：Medical OncologyDOI：10.1007/s12032-019-1249-1
Multicenter prospective study validating the efficacy of a quantitative assessment tool for frailty in patients with urological cancers
来源期刊：Medical OncologyDOI：10.1007/s12032-019-1313-x
Impact of early inflammatory cytokine elevation after commencement of PD-1 inhibitors to predict efficacy in patients with non-small cell lung cancer
来源期刊：Medical OncologyDOI：10.1007/s12032-019-1255-3
Characteristics and impact of programmed death-ligand 1 expression, CD8+ tumor-infiltrating lymphocytes, and p16 status in head and neck squamous cell carcinoma
来源期刊：Medical OncologyDOI：10.1007/s12032-018-1241-1
Programmed death-1 receptor (PD-1) and PD-ligand-1 (PD-L1) expression in non-small cell lung cancer and the immune-suppressive effect of anaerobic glycolysis
来源期刊：Medical OncologyDOI：10.1007/s12032-019-1299-4
Liver graft rejection following immune checkpoint inhibitors treatment: a review
来源期刊：Medical OncologyDOI：10.1007/s12032-019-1316-7
Rhabdomyosarcoma in adults: analysis of treatment modalities in a prospective single-center series
来源期刊：Medical OncologyDOI：10.1007/s12032-019-1282-0
Clinical significance of soluble forms of immune checkpoint molecules in advanced esophageal cancer
来源期刊：Medical OncologyDOI：10.1007/s12032-019-1285-x
Postmastectomy radiation therapy using VMAT technique for breast cancer patients with expander reconstruction
来源期刊：Medical OncologyDOI：10.1007/s12032-019-1275-z
The role of radiotherapy in epithelial ovarian cancer: a literature overview
来源期刊：Medical OncologyDOI：10.1007/s12032-019-1287-8
Metastatic castration resistant prostate cancer with squamous cell, small cell, and sarcomatoid elements—a clinicopathologic and genomic sequencing-based discussion
来源期刊：Medical OncologyDOI：10.1007/s12032-019-1250-8
MicroRNA expression profiling provides novel insights into immune-related pathways involved in gastric cancer
来源期刊：Medical OncologyDOI：10.1007/s12032-019-1305-x
Impact of circulating tumour cells on survival of eribulin-treated patients with metastatic breast cancer
来源期刊：Medical OncologyDOI：10.1007/s12032-019-1314-9
Inhibition of PI3K/AKT/mTOR and MAPK signaling pathways decreases progranulin expression in ovarian clear cell carcinoma (OCCC) cell line: a potential biomarker for therapy response to signaling pathway inhibitors
来源期刊：Medical OncologyDOI：10.1007/s12032-019-1326-5
Friend or foe, the role of EGR-1 in cancer
来源期刊：Medical OncologyDOI：10.1007/s12032-019-1333-6
Mechanism of VIPR1 gene regulating human lung adenocarcinoma H1299 cells
来源期刊：Medical OncologyDOI：10.1007/s12032-019-1312-y
Risk factors, clinical outcomes, and natural history of uveal melanoma: a single-institution analysis
来源期刊：Medical OncologyDOI：10.1007/s12032-018-1230-4
Identification of important invasion and proliferation related genes in adrenocortical carcinoma
来源期刊：Medical OncologyDOI：10.1007/s12032-019-1296-7
Individualized treatment of head neck squamous cell carcinoma patients aged 70 or older with radiotherapy alone or associated to cisplatin or cetuximab: impact of weekly radiation dose on loco-regional control
来源期刊：Medical OncologyDOI：10.1007/s12032-019-1264-2
Prospective assessment of the clinical benefit of a tailored cancer gene set built on a next-generation sequencing platform in patients with recurrent or metastatic head and neck cancer
来源期刊：Medical OncologyDOI：10.1007/s12032-019-1336-3
Circulating CD16+CD56+ nature killer cells indicate the prognosis of colorectal cancer after initial chemotherapy
来源期刊：Medical OncologyDOI：10.1007/s12032-019-1307-8
A study of mechanistic mapping of novel SNPs to male breast cancer
来源期刊：Medical OncologyDOI：10.1007/s12032-019-1290-0
N-Glycosylation in progression of skin cancer
来源期刊：Medical OncologyDOI：10.1007/s12032-019-1270-4
Ubiquitin-specific peptidase 39 regulates the process of proliferation and migration of human ovarian cancer via p53/p21 pathway and EMT
来源期刊：Medical OncologyDOI：10.1007/s12032-019-1308-7
Performance of a new system using a one-step nucleic acid amplification assay for detecting lymph node metastases in breast cancer
来源期刊：Medical OncologyDOI：10.1007/s12032-019-1277-x
MPC-1 expression in myeloma cells is associated with the efficacy of bortezomib therapy
来源期刊：Medical OncologyDOI：10.1007/s12032-019-1298-5
Prospective assessment of taste impairment and nausea during radiotherapy for head and neck cancer
来源期刊：Medical OncologyDOI：10.1007/s12032-019-1269-x
Outcomes in patients\u2009≥\u200980 years with a diagnosis of a hepatopancreaticobiliary (HPB) malignancy
来源期刊：Medical OncologyDOI：10.1007/s12032-019-1310-0
Metronomic chemotherapy with cyclophosphamide plus low dose of corticosteroids in advanced castration-resistant prostate cancer across the era of taxanes and new hormonal drugs
来源期刊：Medical OncologyDOI：10.1007/s12032-019-1304-y
Outcomes of hypercalcemia of malignancy in patients with solid cancer: a national inpatient analysis
来源期刊：Medical OncologyDOI：10.1007/s12032-019-1315-8
In silico identification of key genes and signaling pathways targeted by a panel of signature microRNAs in prostate cancer
来源期刊：Medical OncologyDOI：10.1007/s12032-019-1268-y
Mortality rates and prognostic factors in patients with malignant salivary tumors
来源期刊：Medical OncologyDOI：10.1007/s12032-019-1284-y
Intra- and inter-observer variability in breast tumour bed contouring and the controversial role of surgical clips
来源期刊：Medical OncologyDOI：10.1007/s12032-019-1273-1
Evaluating the decisions of glioma patients regarding clinical trial participation: a retrospective single provider review
来源期刊：Medical OncologyDOI：10.1007/s12032-019-1259-z
A novel role mediated by adenoviral E1A in suppressing cancer through modulating decorin
来源期刊：Medical OncologyDOI：10.1007/s12032-019-1325-6
The correlation between the incidence of adverse events and progression-free survival in patients treated with cabozantinib for metastatic renal cell carcinoma (mRCC)
来源期刊：Medical OncologyDOI：10.1007/s12032-018-1239-8
Hypofractionated radiotherapy combined with cetuximab in vulnerable elderly patients with locally advanced head and neck squamous cell carcinoma
来源期刊：Medical OncologyDOI：10.1007/s12032-019-1292-y
Direct health-care cost of head and neck cancers: a population-based study in north-eastern Italy
来源期刊：Medical OncologyDOI：10.1007/s12032-019-1256-2
Multicenter open-label randomized phase II study of second-line panitumumab and irinotecan with or without fluoropyrimidines in patients with KRAS wild-type metastatic colorectal cancer (PACIFIC study)
来源期刊：Medical OncologyDOI：10.1007/s12032-019-1254-4
First experience of durable cytoreduction in chronic lymphoid leukemia with 177Lu-DOTATATE
来源期刊：Medical OncologyDOI：10.1007/s12032-019-1266-0
Best treatment options for advanced renal cell carcinoma (RCC) patients: a Delphi consensus study
来源期刊：Medical OncologyDOI：10.1007/s12032-019-1251-7
Population-based assessment of the national comprehensive cancer network recommendations for baseline imaging of hepatocellular carcinoma
来源期刊：Medical OncologyDOI：10.1007/s12032-019-1248-2
Can synthetic lethality approach be used with DNA repair genes for primary and secondary MDS?
来源期刊：Medical OncologyDOI：10.1007/s12032-019-1324-7
The prognostic value of circulating myeloblasts in patients with myelodysplastic syndromes treated with azacitidine
来源期刊：Medical OncologyDOI：10.1007/s12032-019-1247-3
Correction to: IL-39 acts as a friend to pancreatic cancer
来源期刊：Medical OncologyDOI：10.1007/s12032-018-1244-y
Vitamin D supplementation and colorectal cancer prognosis
来源期刊：Medical OncologyDOI：10.1007/s12032-019-1293-x
Blood levels of endocrine-disrupting metals and prevalent breast cancer among US women
来源期刊：Medical OncologyDOI：10.1007/s12032-019-1328-3
Basaloid and lobulated: Sebaceous adenoma.
来源期刊：Medical OncologyDOI：10.35841/medical-oncology.4.1.3-7
